BG104839A - Chrystalline form of paroxetine - Google Patents
Chrystalline form of paroxetineInfo
- Publication number
- BG104839A BG104839A BG104839A BG10483900A BG104839A BG 104839 A BG104839 A BG 104839A BG 104839 A BG104839 A BG 104839A BG 10483900 A BG10483900 A BG 10483900A BG 104839 A BG104839 A BG 104839A
- Authority
- BG
- Bulgaria
- Prior art keywords
- paroxetine
- chrystalline
- free
- therapy
- pure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104839A true BG104839A (en) | 2001-09-28 |
Family
ID=27269245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104839A BG104839A (en) | 1998-03-16 | 2000-10-11 | Chrystalline form of paroxetine |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1064282A1 (hu) |
JP (1) | JP2002506865A (hu) |
KR (1) | KR20010041947A (hu) |
CN (1) | CN1300286A (hu) |
AP (1) | AP2000001907A0 (hu) |
AU (1) | AU2847199A (hu) |
BG (1) | BG104839A (hu) |
BR (1) | BR9908825A (hu) |
CA (1) | CA2323896A1 (hu) |
EA (1) | EA200000946A1 (hu) |
HU (1) | HUP0101215A3 (hu) |
ID (1) | ID27596A (hu) |
IL (1) | IL138390A0 (hu) |
NO (1) | NO20004583L (hu) |
PL (1) | PL342931A1 (hu) |
SK (1) | SK13622000A3 (hu) |
TR (1) | TR200002675T2 (hu) |
WO (1) | WO1999047519A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
-
1999
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2847199A (en) | 1999-10-11 |
BR9908825A (pt) | 2000-11-21 |
KR20010041947A (ko) | 2001-05-25 |
IL138390A0 (en) | 2001-10-31 |
HUP0101215A2 (hu) | 2002-04-29 |
HUP0101215A3 (en) | 2002-05-28 |
WO1999047519A1 (en) | 1999-09-23 |
ID27596A (id) | 2001-04-12 |
CN1300286A (zh) | 2001-06-20 |
SK13622000A3 (sk) | 2001-03-12 |
JP2002506865A (ja) | 2002-03-05 |
TR200002675T2 (tr) | 2000-12-21 |
EP1064282A1 (en) | 2001-01-03 |
NO20004583L (no) | 2000-09-15 |
PL342931A1 (en) | 2001-07-16 |
CA2323896A1 (en) | 1999-09-23 |
EA200000946A1 (ru) | 2001-02-26 |
NO20004583D0 (no) | 2000-09-14 |
AP2000001907A0 (en) | 2000-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
MY114014A (en) | Imidazole compounds, compositions and use | |
HU9503605D0 (en) | Use of nona- and decapeptides in the preparation of a drug for the treatment of aids | |
IL125223A0 (en) | Novel substituted imidazole compounds | |
PL327934A1 (en) | Novel substituted imidazole compounds | |
CY2473B1 (en) | New phenanthridines. | |
PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
HK1029922A1 (en) | Angiostatic agents and compositions for treating glc1a glaucoma | |
AU2291097A (en) | Novel phenanthridines substituted in the 6 position | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
HU229458B1 (en) | Pharmaceutical compositions containing zolmitriptan | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
AU2982495A (en) | Heterocycle-condensed morphinoid derivatives | |
MX9707875A (es) | Levobupivacaina y su uso como un anestesico en mujeres embarazadas. | |
IL106237A0 (en) | Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis | |
BG104839A (en) | Chrystalline form of paroxetine | |
NZ515531A (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods | |
BG105204A (en) | Salts of paroxetine | |
BG104914A (en) | Paroxetine maleate | |
ZA9711468B (en) | New use of comt inhibitors | |
AU4944899A (en) | New pharmaceutically active compounds | |
MD980129A (en) | Antiherpetic remedy | |
AP2000001963A0 (en) | Paroxetine ascorbate. | |
BG105549A (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |